A Standard Nonmyeloablative Transplantation Regimen for Adults with Sickle Cell Disease: Are We There Yet?
Open Access
- 1 March 2016
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 22 (3) , 397-398
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell DiseaseTransplantation and Cellular Therapy, 2016
- Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell DiseaseTransplantation and Cellular Therapy, 2016
- Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathiesAmerican Journal of Hematology, 2015
- Hematopoietic Stem Cell Transplantation for Patients with Sickle Cell DiseaseHematology/Oncology Clinics of North America, 2014
- Nonmyeloablative HLA-Matched Sibling Allogeneic Hematopoietic Stem Cell Transplantation for Severe Sickle Cell PhenotypeJAMA, 2014
- Reduced toxicity, myeloablative conditioning with BU, fludarabine, alemtuzumab and SCT from sibling donors in children with sickle cell diseaseBone Marrow Transplantation, 2014
- Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemiaTransplantation and Cellular Therapy, 2003